Metformin: From Mechanisms of Action to Therapies

Abstract : Metformin is currently the first-line drug treatment for type 2 diabetes. Besides its glucose-lowering effect, there is interest in actions of the drug of potential relevance to cardiovascular diseases and cancer. However, the underlying mechanisms of action remain elusive. Convincing data place energy metabolism at the center of metformin’s mechanism of action in diabetes and may also be of importance in cardiovascular diseases and cancer. Metformin-induced activation of the energy-sensor AMPK is well documented, but may not account for all actions of the drug. Here, we summarize current knowledge about the different AMPK-dependent and AMPK-independent mechanisms underlying metformin action.
Type de document :
Article dans une revue
Cell Metabolism, Elsevier, 2014, 20 (6), pp.953-66. 〈10.1016/j.cmet.2014.09.018〉
Liste complète des métadonnées

Littérature citée [113 références]  Voir  Masquer  Télécharger

http://www.hal.inserm.fr/inserm-01171739
Contributeur : Benoit Viollet <>
Soumis le : lundi 6 juillet 2015 - 11:34:45
Dernière modification le : jeudi 11 janvier 2018 - 06:23:10

Fichiers

foretz-metformin-manuscript_HA...
Fichiers produits par l'(les) auteur(s)

Identifiants

Collections

Citation

Marc Foretz, Bruno Guigas, Luc Bertrand, Michael Pollak, Benoit Viollet. Metformin: From Mechanisms of Action to Therapies. Cell Metabolism, Elsevier, 2014, 20 (6), pp.953-66. 〈10.1016/j.cmet.2014.09.018〉. 〈inserm-01171739〉

Partager

Métriques

Consultations de la notice

104

Téléchargements de fichiers

566